Literature DB >> 2393645

The volume-deficient orbit: clinical characteristics, surgical management, and results after extraperiorbital implantation of Silastic block.

G E Rose1, H Sigurdsson, R Collin.   

Abstract

The surgical techniques and results after extraperiorbital implantation of Silastic on the orbital floor of 70 patients are reviewed. In 11 patients the implant was through a subciliary approach and in 59 through an inferolateral cantholysis. The inferolateral cantholysis, a simplification of the McCord and Moses approach to the orbital floor, is particularly suited to this application. The implanted Silastic was retained in 66 patients, with an average follow up of 3.5 years (range less than 1 to 9.5 years), though six required surgery to debulk the anterior end of the implant. Further surgery was required in 27 patients, this generally being to correct the position of either the upper or the lower lid. Volume enhancement was effective in most cases, there being a significant reduction in the degree of recession of the prosthesis and the depth of the unsightly sunken sulci of the upper and lower lids. The mobility of the orbital contents, the prosthesis, and the upper lid was not improved.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393645      PMCID: PMC1042205          DOI: 10.1136/bjo.74.9.545

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Baseball implant. A method of secondary insertion of an intraorbital implant.

Authors:  B R Frueh; G V Felker
Journal:  Arch Ophthalmol       Date:  1976-03

2.  Dermis-fat graft as a movable implant within the muscle cone.

Authors:  B Smith; R Petrelli
Journal:  Am J Ophthalmol       Date:  1978-01       Impact factor: 5.258

3.  Uses of RTV silicone in orbital reconstruction.

Authors:  L M Vistnes; G L Paris
Journal:  Am J Ophthalmol       Date:  1977-04       Impact factor: 5.258

4.  Correction of the superior lid sulcus with subperiosteal implants.

Authors:  D B Soll
Journal:  Arch Ophthalmol       Date:  1971-02

5.  Surgical correction of superior sulcus deformity occurring after enucleation.

Authors:  B E Spivey; L Allen; W B Stewart
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

6.  Autogenous dermis-fat orbital implantation.

Authors:  C Guberina; A Hornblass; M A Meltzer; V Soarez; B Smith
Journal:  Arch Ophthalmol       Date:  1983-10

7.  Orbital implants and post enucleation socket syndrome.

Authors:  A G Tyers; J R Collin
Journal:  Trans Ophthalmol Soc U K       Date:  1982-04

8.  An autogenous kinetic dermis-fat orbital implant: an updated technique.

Authors:  B Smith; S L Bosniak; R D Lisman
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

9.  The anophthalmic socket.

Authors:  D B Soll
Journal:  Ophthalmology       Date:  1982-05       Impact factor: 12.079

10.  The use of room temperature vulcanizing silicone in anophthalmic enophthalmos.

Authors:  R W Neuhaus; N Shorr
Journal:  Am J Ophthalmol       Date:  1982-09       Impact factor: 5.258

View more
  5 in total

1.  Dermofat grafts to the extraconal orbital space.

Authors:  G E Rose; R Collin
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

2.  Use of Proplast II as a subperiosteal implant for the correction of anophthalmic enophthalmos.

Authors:  S Shah; M Rhatigan; R Sampath; C Yeoman; S Sunderland; R Brammer; B Leatherbarrow
Journal:  Br J Ophthalmol       Date:  1995-09       Impact factor: 4.638

3.  Prosthetic Correction of Postenucleation Socket Syndrome: A Case Report.

Authors:  Vikas B Kamble
Journal:  J Indian Prosthodont Soc       Date:  2012-09-29

4.  Evisceration in the modern age.

Authors:  Laura T Phan; Thomas N Hwang; Timothy J McCulley
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

5.  Injectable silicone rubber for ocular implantation after evisceration.

Authors:  Peng Fei Zheng; Qi Sheng You; Qian Li; Hong Yan Deng; Ian Y H Wong; Xiao Yan Peng
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.